Why the study?
Finding an optimum epicardial pacing site in children needing lead replacement can be challenging.
Does the implantation of transvenous SelectSecure leads in the epicardial position provide acceptable pacing parameters in patients needing lead replacement?
Population
6 patients (5 children and 1 adult) receiving epicardial lead replacement
Comparison
Transvenous SelectSecure 3830 leads in the epicardial position
Design
Case series
Follow-up
23.4 (8-32) months
Key result
Implantation of transvenous SelectSecure leads in the epicardial position was feasible in patients with congenital heart disease and epicardial scarring, maintaining acceptable pacing parameters over a median 27-month follow-up.
Authors
Loading...
Supports feasibility of epicardial SelectSecure leads in select pediatric reoperations; leaves open need for larger prospective studies.
Observational (n=6)
No
Does the implantation of transvenous SelectSecure leads in the epicardial position provide acceptable pacing parameters in patients needing lead replacement?
The off-label use of transvenous SelectSecure leads in the epicardial position is feasible and provides acceptable midterm pacing parameters for patients with multiple previous surgeries.
Brütsch et al. (2025) conducted an observational in Congenital heart disease requiring permanent pacing (n=6). Transvenous SelectSecure 3830 leads in epicardial position was evaluated on Feasibility and lead performance (pacing threshold, sensing, and impedance). Implantation of transvenous SelectSecure leads in the epicardial position was feasible in patients with congenital heart disease and epicardial scarring, maintaining acceptable pacing parameters over a median 27-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: